Acute kidney injury in Staphylococcus aureus bacteraemia: a recurrent events analysis
Clinical Microbiology and Infection · 2024-10 · 30 (10) · 1270-1275
DOI: 10.1016/j.cmi.2024.06.017 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Microbiology and Infection, 2024-10. Verfasst von David T P Buis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Amsterdam Institute for Infection a…. Hauptthemen laut MEDLINE: Bacteremia, Acute Kidney Injury, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.
Abstract (Originalsprache)
OBJECTIVES: To estimate risk factors for acute kidney injury (AKI) and the effect of AKI on mortality in Staphylococcus aureus bacteraemia, while taking into account recurrent AKI episodes, competing risks, time-varying variables, and time-varying effects. METHODS: We performed an unplanned analysis using data from a multicentre cohort study of patients with Staphylococcus aureus bacteraemia (SAB). The primary outcome was cumulative incidence of AKI, according to Kidney Disease Improving Global Outcomes definitions. RESULTS: We included 453 patients in this study of whom 194 (43%) patients experienced one or more AKI episodes. Age (hazard ratio (HR) 1.013, 95% CI 1.001-1.024), Charlson comorbidity index (HR 1.07, 95% CI 1.01-1.14), prior chronic kidney disease (HR 1.76, 95% CI 1.28-2.42), septic shock (HR 3.28, 95% CI 2.31-4.66), persistent bacteraemia (HR 1.53, 95% CI 1.08-2.17), and vancomycin therapy (HR 1.80, 95% CI 1.05-3.09) were independently associated with AKI, but flucloxacillin, cefazolin, rifampicin, and aminoglycoside therapy were not. After adjustment for confounders and immortal time bias, AKI was associated with an increased risk of 90-day mortality (HR 4.26, 95% CI 2.91-6.23). DISCUSSION: The incidence of AKI in SAB is high and a substantial proportion of patients develop recurrent episodes of AKI after recovery. AKI is specifically linked to the use of vancomycin and not to anti-staphylococcal penicillins. The clinical outcome of patients with SAB complicated by AKI is worse than previously estimated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands. Electronic address: d.t.p.bui…
- Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands; Department of Internal Medicine, Amsterdam UMC Location Universiteit van Amsterdam, Amsterdam, the Netherlands; Julius Center for Health Scienc…
- Department of Internal Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
- Department of Internal Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands; Department of Internal Medicine, Amsterdam UMC Location Universiteit van Amsterdam, Amsterdam, the Netherlands.
- Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Utrecht, the Netherlands; European Clinical Research Alliance on Infectious Diseases, Utrecht, the Netherlands.
Förderung
- ZonMw
Zitieren
APA
Buis, D. T. P., van der Vaart, T. W., Mohan, A., Prins, J. M., van der Meer, J. T. M., Bonten, M. J. M., Jakulj, L., van Werkhoven, C. H., & Sigaloff, K. C. E. (2024). Acute kidney injury in Staphylococcus aureus bacteraemia: a recurrent events analysis. Clinical Microbiology and Infection, 30(10), 1270-1275. https://doi.org/10.1016/j.cmi.2024.06.017
Vancouver
Buis DTP, van der Vaart TW, Mohan A, Prins JM, van der Meer JTM, Bonten MJM, et al. Acute kidney injury in Staphylococcus aureus bacteraemia: a recurrent events analysis. Clinical Microbiology and Infection. 2024;30(10):1270-1275. doi:10.1016/j.cmi.2024.06.017
BibTeX
@article{Buis2024,
author = {Buis, David T P and van der Vaart, Thomas W and Mohan, Asna and Prins, Jan M and van der Meer, Jan T M and Bonten, Marc J M and Jakulj, Lily and van Werkhoven, Cornelis H and Sigaloff, Kim C E},
title = {Acute kidney injury in Staphylococcus aureus bacteraemia: a recurrent events analysis},
journal = {Clinical Microbiology and Infection},
year = {2024},
volume = {30},
number = {10},
pages = {1270--1275},
doi = {10.1016/j.cmi.2024.06.017}
}
EUVIMED